Back to top

Aggressive Growth

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Bio-Reference Labs (BRLI - Snapshot Report) recently beat earnings estimates once again. Shares are up roughly 10% since being featured as a Zacks Rank Buy in December.

Company Description

Bio-Reference Laboratories, Inc provides clinical laboratory testing services such as blood and urine analysis in the New York metropolitan area. The company was founded in 1981 and has a market cap of $536 million.

Another Surprise

On Mar 4 Bio-Reference reported first-quarter results that included a 31% jump in revenue. The growth came on over patient growth as well as revenue per patient.

Earnings per shares came in at 29 cents, 6 cents ahead of expectations. Bio-Referance has now topped estimates 7 times in a row.

Analysts React

Bio-Reference analysts raised their estimates following the news. The Zacks Consensus Estimate for fiscal 2010 is up 4 cents to $1.81. Forecasts for 2011 are averaging $2.13, up a penny.

If projections are met, earnings growth rates will be 20% for this year and another 18% next year.

Read the December Feature Here

Last Week's Aggressive Growth Zacks Rank Buy Stocks

Lennar Corp. (LEN) reported optimistic results in the face of an uncertain housing market. Shares and estimates are surging. Read Full Article.

Continental Airlines (CAL) estimates are rising at a break-neck pace and shares just set a new multi-year high. Read Full Article.

Schawk Inc. (SGK) just beat expectations and shares are soaring yet, thanks to rapidly rising estimates, remain a great value with plenty of growth. Read Full Article.

Cenveo, Inc (CVO) recently beat Wall Street's expectations, sending shares to a new 52-week high. Thanks to upward estimate revisions, shares are still a good value. Read Full Article.

Bill Wilton is the Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Growth Trader service

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
LAKE SHORE G LSG 0.77 +6.05%
QUESTCOR PHA QCOR 80.07 +2.47%
VIPSHOP HOLD VIPS 156.35 +1.82%
ENLINK MIDST ENLC 36.29 +1.60%
BNC BANCORP BNCN 17.33 +1.58%